New Foundayo weight loss pill approved by FDA
Digest more
In phase 3 clinical trials, orforglipron was associated with significant reductions in mean percent body weight compared with placebo in patients with and without type 2 diabetes.
What to know about Foundayo, the newest option if injections aren’t your thing.
Losing weight can definitely help lower blood pressure. Research shows that losing about 11 pounds (5 kilograms) reduces ...
By Christy Santhosh March 19 (Reuters) - Eli Lilly's next-generation obesity drug showed a significant reduction in blood sugar levels and weight in a late-stage trial, the company said on Thursday, ...
Data from the phase 3b STEP UP trial demonstrate that the 7.2 mg semaglutide dose provides superior weight reduction compared with the 2.4 mg dose and placebo.
Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New ...
If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to nutrition, exercise and medications, some might explore the idea of weight ...
On Monday, Novo Nordisk A/S (NYSE:NVO) announced headline results from the REDEFINE 2 phase 3 trial in the global REDEFINE program. REDEFINE 2 is a 68-week efficacy and safety trial investigating once ...
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And ...
How Does Topirmate for Weight Loss Work? This article was reviewed by Mike Bohl, MD, MBA, MPH, MS, ALM. Topiramate, also sold under the brand name Topamax, is a drug approved by the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results